Target intelligence / Profile preview

Reticulophagy regulator 2 (RETREG2)

Target
RETREG2
Molecular classification
Other (ER-phagy receptor), not classified as a conventional receptor, enzyme, transporter, or transcription factor
01

Overview

Reticulophagy regulator 2 (RETREG2) is a protein anchored in the endoplasmic reticulum (ER) membrane that functions as an ER-phagy receptor, helping regulate selective autophagy of the ER (termed "reticulophagy")[1][2][3][4]. RETREG2 is typically inactive under normal conditions but becomes activated following cellular stress, where it mediates ER fragmentation and facilitates sequestration of ER fragments into autophagosomes for lysosomal degradation through interaction with ATG8 family proteins[1][3][4]. This mechanism is important for maintenance of ER morphology, protein/collagen quality control, and adaptation to stress; dysfunction of RETREG2 has been linked to some forms of hereditary sensory and autonomic neuropathy[1][2][4][7]. Unlike classical drug targets such as receptors or enzymes, RETREG2 is not currently considered a therapeutic target and no drugs are known to directly modulate its function[1][2][3][4].

Other names
C2orf17FAM134AMAG2MGC3035MAG-2family with sequence similarity 134 member Ametastasis associated gene-2protein FAM134A
02

Biological functions

Autophagy regulation (specifically ER-phagy/reticulophagy)Endoplasmic reticulum organizationCollagen catabolic process (collagen quality control)Membrane curvature induction and ER fragmentationProtein homeostasis maintenance
03

Disease associations

Neuropathy, hereditary sensory and autonomic, type IIBHereditary sensory and autonomic neuropathy type 2Other potential roles in ER stress-associated pathologies

Beyond the preview

Go deeper on Reticulophagy regulator 2 (RETREG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reticulophagy regulator 2 (RETREG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call